Medication Access Pennsylvania seeks to ensure everyone in the state can afford the medications that are essential to living a healthy life. #MedAccessPA#SB841
Many patients face financial hardships because of copay accumulator adjustments that exclude copay assistance from counting toward their deductibles and out-of-pocket maximum. Join the fight to help patients access affordable, lifesaving medications. https://t.co/2Vf0HihWwt
Copay accumulator adjustments harm patients by excluding copay assistance from counting toward insurance deductibles and out-of-pocket maximums for prescription drug costs. Want to help put a stop to this? Visit our site to learn more! https://t.co/x1wldJs5D5
Big PBMs say “Drugmakers alone have the power to set prices.”
Then how is that the same PBM set five different prices for the same drug, at the same pharmacy, on the same day, where the delta between the bookends had an over 10x difference?
Our latest: https://t.co/mKiwV7UmYb
At every turn, Maria Shoemaker has been met with harmful practices at the hands of insurers and prescription drug middlemen. Read her story to learn how pharmacy benefit managers (PBMs) keep patients from accessing and affording lifesaving medications. https://t.co/oB9EYBBkdQ
At last, it's time for a victory lap! Years of work by patient and provider advocates from across the state were rewarded yesterday as the legislature passed legislation to create reforms to the practices of prior authorization and step therapy. CONGRATS!
https://t.co/ZF5kF57Uie
Tell your lawmaker it’s time to pass prior authorization and step therapy reform. The state House is nearing a vote on this crucial issue that will change the lives of countless Pennsylvania patients. Send a message here! https://t.co/W7wGQCDWRx
It’s time to reform prior authorization and step therapy — patients have waited long enough. Visit our page to learn more about Senate Bill 225 and send a message directly to your state senator asking them to vote yes on this important legislation.
https://t.co/dswpQQFwWi
Biosimilar drugs have potential for great savings in the U.S. — but too few have been approved. A new executive order could help change that.
https://t.co/6hhJagkiTW
The more that insurers come between patients and their providers, the worse outcomes are. There are legislative solutions to protect this relationship — our lawmakers must embrace them.
https://t.co/pRH0p6L3qO
"Without step therapy requirements, I truly believe I could have avoided surgery — and, ironically, my insurer would have paid less for my treatments," writes a patient who is supporting legislation to reform step therapy guidelines in Pennsylvania. https://t.co/tCvT26EAZk
Last week in Harrisburg, advocates for prior authorization and step therapy reform shared their powerful stories of how the insurance practices have harmed their lives.
https://t.co/mXdN7LytEq
No patient’s quality of life should be impacted by health insurance delays. Click here as dermatitis patient, Angela Weeks, explain her struggles with prior authorization. https://t.co/8YS7rrb90D
H.R. 3, which is aimed at lowering health care costs, includes some positive components, such as proposals to cap out-of-pocket costs for Medicare Part D beneficiaries. But it also has a major flaw.
https://t.co/CYoIp8Vily
A Pennsylvania pharmacist argues that when our lawmakers responsibly foster more competition in the prescription drug market, we all win. Learn more: https://t.co/yzr8lrjs7G
Have a story about how prior authorization or step therapy affected you? Or rising out-of-pocket drug costs? We want to hear it.
https://t.co/EbW53AZBeV
When insurers undercut the provider-patient relationship, it causes harm. This patient story explains how being denied a prescribed treatment created a negative impact on her quality of life.
https://t.co/Xll2zlQk82